Crescent Biopharma to Present at March Investor Conferences

Core Viewpoint - Crescent Biopharma is focused on advancing innovative cancer therapies and will present at key investor conferences in March 2026 [1][3]. Company Overview - Crescent Biopharma aims to become a leading oncology company by developing next-generation therapies for cancer patients [2]. - The company's clinical-stage pipeline includes a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates (ADCs) [2]. - Crescent intends to leverage multiple modalities and established targets to develop transformative therapies for various solid tumors [2]. Upcoming Events - Crescent Biopharma will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026, at 3:50 p.m. ET in Boston [3]. - The company will also be featured in the Leerink Partners 2026 Global Healthcare Conference on March 11, 2026, at 8:40 a.m. ET in Miami [3].